SAN FRANCISCO — Dr. Thomas Insel is one of the most high-profile scientists who has departed Verily Life Sciences, the Google spinoff that has been plagued by turnover at the top and questions about its approach to science.

Insel, a neuroscientist and longtime head of the National Institute of Mental Health, left for a venture that he says could use people’s behavior on smartphones — such as the speed and cadence of their typing and scrolling — to improve diagnosis and treatment of mental health. The idea, he said in an interview, is to apply the kind of precision approach used for cancer or heart disease to “predict and preempt” serious mental illness.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I’m editor of STAT Plus, STAT’s subscriber-only service for pharma, biotech, business, and policy coverage. STAT is a sister publication to the Globe, which means that we are separate. Globe editors will sometimes present STAT and STAT Plus stories that they think Globe readers would find interesting, in much the same way that some newsletters will aggregate links to a variety of other media outlets with distinct subscription services to add context and value for their readership.

    At this time STAT and the Globe do not have a bundled subscription service, and as such our subscription entities are distinct. That said, we do offer a 25 percent discount to Globe subscribers if they are interested in STAT Plus. You can use the code GLOBE17 at checkout ( to redeem this offer. Or, you can learn more about STAT Plus here:

    Liz Cooney

  • So – Mark responded that he agreed.
    Is Mark from STAT or The Boston Globe?
    And – now what?

  • Why do I need to subscribe to STAT –
    as it is listed as a Boston Globe article?
    It seems to me that if the Boston Globe puts the article in their paper,
    they should provide the article…..
    Please respond.
    Thank you,
    Laurie Abrams-Hall

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy